Panacea Biotec, India's second largest biotechnology company and WHO pre-qualified vaccine major, has received an award notification for supply of its EasyFive (pentavalent vaccine) worth US$222.37 million (Rs 1,067 crore), from UNICEF for years 2010, 2011 and 2012.
The details can be read here.
No comments:
Post a Comment